Illinois has enacted Senate Bill 3222, imposing new regulations on Delta-8 and other hemp-derived cannabinoids. The legislation prohibits the sale of these products to individuals under the age of 21, effective November 2024. Key provisions include requirements for altered product packaging and labeling to clearly indicate they contain psychoactive substances. Further changes regarding testing and manufacturing standards are scheduled to take effect in 2026. The law aims to address concerns about youth access and potential health risks associated with these increasingly popular products. Retailers must now verify age and comply with the new packaging guidelines to avoid penalties. The bill’s passage reflects a growing national trend of states regulating the rapidly expanding hemp-derived cannabinoid market.